{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:29:37Z","timestamp":1792859377487,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Heilongjiang Natural Science Foundation","award":["ZD201701"],"award-info":[{"award-number":["ZD201701"]}]},{"name":"Chunhui plan\" cooperative scientific research project of the Ministry of education of China","award":["HLJ2019021"],"award-info":[{"award-number":["HLJ2019021"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81271646"],"award-info":[{"award-number":["81271646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Provincial Youth Science fund of Heilongjiang Province","award":["QC2016106"],"award-info":[{"award-number":["QC2016106"]}]},{"name":"Cultivating Fund of the Fourth Affiliated Hospital of Harbin Medical University","award":["HYDSYPY201508"],"award-info":[{"award-number":["HYDSYPY201508"]}]},{"name":"the Health and Family Planning Commission of Heilongjiang Province","award":["2016-119"],"award-info":[{"award-number":["2016-119"]}]},{"name":"Post-doctoral Funding from the government of Heilongjiang Province","award":["LBH215-178"],"award-info":[{"award-number":["LBH215-178"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,11,11]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The NLRP3 inflammasome is closely related to diabetes and atherosclerosis. Recent studies suggest NIMA-related kinase 7 (NEK7) is necessary for NLRP3 inflammasome activation during potassium efflux. However, the expression of the NEK7\/NLRP3 inflammasome pathway in diabetic lower extremity arterial disease (DLEAD) is unclear. The present study aimed to explore whether the NEK7\/NLRP3 inflammasome pathway is involved in the pathogenesis of DLEAD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>The serum levels of interleukin-1\u03b2 (IL-1\u03b2) and IL-18 in the control group (n=39), diabetes without lower extremity artery diseases group (n=39) and DLEAD group (n=85) were measured. H&amp;E and Von Kossa staining were used to observe the vasculature of amputated feet from patients with diabetic foot. Furthermore, immunohistochemical staining, immunofluorescence and western blot were used to detect the expression of NEK7 and the NLRP3 inflammasome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The serum IL-1\u03b2 level in the DLEAD group was significantly increased compared with that in the control group and diabetes without lower extremity artery disease group. The serum IL-18 level was significantly higher in the DLEAD group and diabetes without lower extremity artery disease group than in the control group. H&amp;E staining showed that the subintimal tissue of the arteries of patients with diabetic foot were highly thickened and exhibited irregular atherosclerotic plaques, and the arterial lumen was nearly occluded. Von Kossa staining showed dense brown-black calcium salt deposits in the vascular mesangium. Moreover, the expression of NEK7 and the NLRP3 inflammasome was significantly increased in the vascular cells of patients with diabetic foot, especially in vascular smooth muscle cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The NEK7\/NLRP3 inflammasome pathway might be involved in the pathogenesis of DLEAD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001808","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T17:45:36Z","timestamp":1608140736000},"page":"e001808","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Expression of the NEK7\/NLRP3 inflammasome pathway in patients with diabetic lower extremity arterial disease"],"prefix":"10.1136","volume":"8","author":[{"given":"HuaiQiu","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Ultrasonography, Fourth Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopeadic Surgery, Fourth Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fourth Hospital of Harbin Medical University, Harbin, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0279-2983","authenticated-orcid":false,"given":"XiaoQiu","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Ultrasonography, Fourth Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"2025073112281044000_8.2.e001808.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2018.01.009","article-title":"Diabetic macroangiopathy: pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage","volume":"107","author":"Madonna","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"2025073112281044000_8.2.e001808.2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV17014"},{"key":"2025073112281044000_8.2.e001808.3","doi-asserted-by":"publisher","DOI":"10.1038\/nature10759"},{"key":"2025073112281044000_8.2.e001808.4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"key":"2025073112281044000_8.2.e001808.5","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121595","article-title":"Nlrp3 inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus","volume":"8","author":"Ferreira","year":"2019","journal-title":"Cells"},{"key":"2025073112281044000_8.2.e001808.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025073112281044000_8.2.e001808.7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2022"},{"key":"2025073112281044000_8.2.e001808.8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cardfail.2015.01.002","article-title":"Cortistatin inhibits NLRP3 inflammasome activation of cardiac fibroblasts during sepsis","volume":"21","author":"Zhang","year":"2015","journal-title":"J Card Fail"},{"key":"2025073112281044000_8.2.e001808.9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"2025073112281044000_8.2.e001808.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000227"},{"key":"2025073112281044000_8.2.e001808.11","doi-asserted-by":"publisher","DOI":"10.1038\/nature16959"},{"key":"2025073112281044000_8.2.e001808.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04947-6"},{"key":"2025073112281044000_8.2.e001808.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-018-0192-9","article-title":"Expression and clinical significance of the NEK7-NLRP3 inflammasome signaling pathway in patients with systemic lupus erythematosus","volume":"15","author":"Ma","year":"2018","journal-title":"J Inflamm"},{"key":"2025073112281044000_8.2.e001808.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr211"},{"key":"2025073112281044000_8.2.e001808.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01592","article-title":"Regulatory mechanisms of the NLRP3 inflammasome, a novel immune-inflammatory marker in cardiovascular diseases","volume":"10","author":"An","year":"2019","journal-title":"Front Immunol"},{"key":"2025073112281044000_8.2.e001808.16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-Dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"2025073112281044000_8.2.e001808.17","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.306256"},{"key":"2025073112281044000_8.2.e001808.18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01058"},{"key":"2025073112281044000_8.2.e001808.19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00363","article-title":"IL-1\u03b2 Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus","volume":"8","author":"Peir\u00f3","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025073112281044000_8.2.e001808.20","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvv107"},{"key":"2025073112281044000_8.2.e001808.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024"},{"key":"2025073112281044000_8.2.e001808.22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20130043","article-title":"Nlrp3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin","volume":"126","author":"Satoh","year":"2014","journal-title":"Clin Sci"},{"key":"2025073112281044000_8.2.e001808.23","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0595-2"},{"key":"2025073112281044000_8.2.e001808.24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003031"},{"key":"2025073112281044000_8.2.e001808.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.01.211"},{"key":"2025073112281044000_8.2.e001808.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.01.009"},{"key":"2025073112281044000_8.2.e001808.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1295-z"},{"key":"2025073112281044000_8.2.e001808.28","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3333"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:28:21Z","timestamp":1753990101000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,12,15]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/bmjdrc-2020-001808"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001808","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}